FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE | 0280-8015-24 | Bayer HealthCare LLC | M027 | HUMAN OTC DRUG | OTC Monograph Drug |
PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN | 47682-049-99 | Unifirst First Aid Corporation | M027 | HUMAN OTC DRUG | OTC Monograph Drug |
PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN | 49314-8238-0 | Unishield | M027 | HUMAN OTC DRUG | OTC Monograph Drug |
PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN | 73408-923-80 | Thompson Safety | M027 | HUMAN OTC DRUG | OTC Monograph Drug |
PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN | 47682-049-80 | Unifirst First Aid Corporation | M027 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 51672-2115-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2114-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 63629-8240-1 | Bryant Ranch Prepack | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2114-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2114-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2117-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2117-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-309-01 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-10 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-24 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-31 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-309-02 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-25 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-32 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-29 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-30 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE | 0591-3220-01 | Actavis Pharma, Inc. | NDA020232 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-91 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-09 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 52904-871-04 | Select Corporation | NDA020802 | HUMAN OTC DRUG | NDA |
-